Loading...
Loading...
PACB| Name | Value |
|---|---|
| Revenues | 38.8M |
| Cost of Revenue | 34.4M |
| Gross Profit | 4.4M |
| Operating Expense | 85.9M |
| Operating I/L | -81.4M |
| Other Income/Expense | 3.2M |
| Interest Income | 0.0M |
| Pretax | -78.2M |
| Income Tax Expense | 12.0M |
| Net Income/Loss | -78.2M |
Pacific Biosciences of California, Inc. specializes in designing, developing, and manufacturing sequencing systems for genetic analysis. The company offers PacBio's Systems for conducting and analyzing sequencing reactions, consumable products like single molecule real-time (SMRT) cells, and various reagent kits for specific workflows. Its products cater to research institutions, commercial laboratories, genome centers, public health labs, hospitals, clinical research institutes, pharmaceutical companies, and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America.
